General Atlantic’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,000,000
Closed -$67.2M 20
2024
Q1
$67.2M Hold
4,000,000
1.56% 12
2023
Q4
$72.4M Hold
4,000,000
1.04% 12
2023
Q3
$67.8M Hold
4,000,000
1.05% 15
2023
Q2
$48M Hold
4,000,000
0.76% 19
2023
Q1
$52.1M Hold
4,000,000
0.61% 17
2022
Q4
$59.1M Hold
4,000,000
0.78% 16
2022
Q3
$35.4M Hold
4,000,000
0.42% 20
2022
Q2
$50.6M Hold
4,000,000
0.66% 17
2022
Q1
$75.7M Hold
4,000,000
0.69% 13
2021
Q4
$140M Hold
4,000,000
1.08% 13
2021
Q3
$146M Buy
+4,000,000
New +$157M 0.86% 14

Other funds holding HCM

General Atlantic's HCM Position: Q2 2024 in Review

General Atlantic sold out of HUTCHMED (HCM) in Q2 2024, closing a stake of 4,000,000 shares — an estimated $67.2M sold.

General Atlantic first reported a position in HCM in Q3 2021 and held it in 11 quarters. The position peaked at $146M in Q3 2021. 67 funds tracked by Wall St. Rank hold HCM as of Q2 2024.

  • General Atlantic reported no remaining HUTCHMED position as of Q2 2024 after selling out during the quarter.
  • General Atlantic sold 4,000,000 HUTCHMED shares in Q2 2024, an estimated $67.2M.
  • General Atlantic first reported a position in HUTCHMED in Q3 2021 and held it in 11 quarters.
  • General Atlantic's HUTCHMED position peaked at $146M in Q3 2021.
  • 67 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2024.

Based on General Atlantic's 13F filing for Q2 2024, filed 14 Aug 2024.